Vitamin D Testing Market to Grow by USD 182.6 Million from 2024-2028, as Awareness of Vitamin D's Role in Health and Immunity Boosts Demand, Report on How AI is Redefining Market Landscape - Technavio

NEW YORK, Feb. 4, 2025 /PRNewswire/ -- Report with market evolution powered by AI - The global Vitamin D testing market size is estimated to grow by USD 182.6 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of over 4.96%  during the forecast period. Growing awareness of importance of vitamin D to health and immunity is driving market growth, with a trend towards increasing prevalence of infections and autoimmune diseases. However, product recalls posing challenges to manufacturers  poses a challenge. Key market players include Beckman Coulter Inc., Biohit Oyj, bioMerieux SA, BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSorin SpA, DiaSys Diagnostic Systems GmbH, Everly Health Inc., F. Hoffmann La Roche Ltd., Laboratory Corp. Of America Holdings, Qualigen Therapeutics Inc., Quest Diagnostics Inc., Quidelortho Corp., Randox Laboratories Ltd., Recipe Chemicals and Instruments GmbH, Revvity Inc., Siemens AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Tosoh Corp..

Key insights into market evolution with AI-powered analysis. Explore trends, segmentation, and growth drivers- View Free Sample PDF

Vitamin D Testing Market Scope
Report Coverage	Details
Base year	2023
Historic period	2018 - 2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 4.96%
Market growth 2024-2028	USD 182.6 million
Market structure	Fragmented
YoY growth 2022-2023 (%)	4.63
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 35%
Key countries	US, Germany, China, UK, and Canada
Key companies profiled	Beckman Coulter Inc., Biohit Oyj, bioMerieux SA, BioVendor Laboratorni medicina AS, Boditech Med Inc., DiaSorin SpA, DiaSys Diagnostic Systems GmbH, Everly Health Inc., F. Hoffmann La Roche Ltd., Laboratory Corp. Of America Holdings, Qualigen Therapeutics Inc., Quest Diagnostics Inc., Quidelortho Corp., Randox Laboratories Ltd., Recipe Chemicals and Instruments GmbH, Revvity Inc., Siemens AG, Tecan Trading AG, Thermo Fisher Scientific Inc., and Tosoh Corp.

Market Driver

Vitamin D testing is a significant market with growing trends in diagnosing deficiencies related to Calcium, Magnesium, Phosphate, and Vitamin D itself. Osteoporosis and Rickets are common bone disorders linked to abnormal levels of these nutrients. Radioimmunoassay and HPLC are popular testing methods for Vitamin D in hospitals, diagnostic laboratories, home care, and standalone clinical laboratories. Reimbursement policies and awareness campaigns are crucial for early diagnosis and treatment of Vitamin D deficiency. Sedentary lifestyles and insufficient sunlight exposure contribute to the rising prevalence of deficiencies. Vitamin D is a fat-soluble nutrient essential for strong bones, teeth, and immune system regulation. Abnormal levels can lead to weakness, fatigue, muscle aches, and muscle twitching, among other symptoms. Populations at risk include infants, children, the elderly, pregnant women, and those with nutrition issues, organ damage, or medical conditions. Preventive healthcare and diagnostic tests play a vital role in addressing deficiencies and associated health issues. Health organizations and healthcare authorities are promoting awareness campaigns, events, and initiatives to expand the global presence and production capacities of Vitamin D testing. Vitamin D is a steroid prohormone that plays a role in calcium and phosphate absorption. Abnormal levels can lead to various health issues, including bone changes, fractures, and developmental delay. 25 hydroxy vitamin D is the most common form of Vitamin D tested in blood samples, with a half-life of approximately two weeks. Private agencies are also offering Vitamin D testing services to cater to the growing demand. 

Vitamin D is a crucial nutrient for managing the immune system, with vitamin D receptors present in B cells, T cells, and antigen-presenting cells. These immune cells can synthesize active vitamin D metabolites, allowing the vitamin to regulate both innate and adaptive immune responses. Vitamin D deficiency is linked to increased autoimmunity and susceptibility to various infections, including those caused by bacteria, viruses, fungi, and parasites. Historically, vitamin D in the form of cod liver oil has been used to treat tuberculosis and boost immunity against other infections. The vitamin D testing market is significant due to the growing awareness of its role in immune health and the increasing prevalence of vitamin D deficiency. 

Request Sample of our comprehensive report now to stay ahead in the AI-driven market evolution!

 Market Challenges

• The Vitamin D testing market is witnessing significant growth due to the rising prevalence of bone disorders like osteoporosis and rickets, as well as nutrition issues leading to deficiencies. Factors such as sedentary lifestyles and limited sunlight exposure contribute to Vitamin D deficiency. Hospitals and diagnostic laboratories are major consumers of Vitamin D tests, with home care and standalone clinical laboratories also gaining traction. Reimbursement policies vary, posing challenges for market growth. Vitamin D is essential for strong bones and teeth, and its deficiency can lead to abnormal levels of calcium, phosphate, and magnesium in the blood. Symptoms include weakness, fatigue, muscle aches, and muscle twitching. Vitamin D is a fat-soluble nutrient that plays a role in immune system regulation and bone health. Testing methods include Radioimmunoassay and HPLC. New market initiatives include awareness campaigns, events, and private agencies offering Vitamin D testing. Health organizations and healthcare authorities are promoting preventive healthcare and early diagnosis through diagnostic tests. Vitamin D is a steroid prohormone with a half-life of around 2 weeks, and its deficiency can lead to organ damage and medical conditions like osteomalacia, developmental delay, and fractures. Populations at risk include infants, children, the elderly, pregnant women, and those with certain medical conditions. Global presence and production capacities are expanding to meet the increasing demand for Vitamin D testing. The market is expected to continue growing as awareness of the importance of Vitamin D for overall health increases.
  
  
• Product recalls can significantly impact a company's financial performance and brand reputation. The US Food and Drug Administration (FDA) recall of F. Hoffmann-La Roche's Elecsys Vitamin D total II, due to manufacturing errors leading to falsely elevated results, is a case in point. Such recalls can hinder a manufacturer's product innovation process, enabling competitors to gain an edge. Timely innovation is crucial in competitive markets, and companies must ensure product quality to maintain consumer trust and confidence. The FDA's role in ensuring product safety is essential to protect public health and prevent potential health risks associated with faulty vitamin D tests.

Discover how AI is revolutionizing market trends- Get your access now!

Segment Overview 

This vitamin D testing market report extensively covers market segmentation by  

• Product
• 25-hydroxyvitamin D Testing
• 1 25-dihydroxyvitamin D Testing
• End-user
• Diagnostic Laboratories
• Hospitals And Physician Clinics
• Home Care Settings
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)
• Technology
• Radioimmunoassay
• ELISA
• LC-MS
• Others
• Indication
• Osteoporosis
• Rickets
• Thyroid Disorders
• Vitamin D Deficiency
• Others

1.1 25-hydroxyvitamin D testing-  The 25-hydroxyvitamin D segment dominated the global vitamin D testing market in 2022, accounting for the largest share. This is due to the importance of 25-hydroxyvitamin D in indicating vitamin D levels in the body. Vitamin D is essential for various bodily functions, including modulation of cell growth, neuromuscular and immune function, and reduction of inflammation. The two forms of vitamin D, D2 and D3, are converted into 25-hydroxyvitamin D in the liver before being further metabolized in the kidney. The Institute of Medicine defines vitamin D deficiency as a blood concentration of 25-hydroxyvitamin D below 12ng/mL. A simple blood test is used to determine 25-hydroxyvitamin D levels, which is crucial for diagnosing conditions such as osteoporosis and rickets. Vendors like DiaSorin offer automated immunoassays, such as LIAISON 25 OH Vitamin D TOTAL Assay, for reliable and quick determination of vitamin D status. The rising prevalence of vitamin D deficiency, particularly among children, will fuel market growth during the forecast period.

Download a Sample of our comprehensive report today to discover how AI-driven innovations are reshaping competitive dynamics

Research Analysis

Vitamin D is an essential nutrient that plays a crucial role in maintaining strong bones and teeth by regulating the absorption of calcium and phosphate from the diet. Deficiency in Vitamin D can lead to bone disorders such as osteoporosis and rickets. Abnormal levels of Vitamin D in the blood can be determined through various diagnostic methods including Radioimmunoassay and HPLC. Hospitals and diagnostic laboratories are major contributors to Vitamin D testing, while home care settings are also gaining popularity. Reimbursement policies vary across regions and countries. Sedentary lifestyles and lack of sunlight exposure are major risk factors for Vitamin D deficiency. Nutrition issues, medical conditions, and organ damage can also lead to abnormal levels of Vitamin D in the body. Phosphorus, magnesium, and other minerals are essential co-factors for Vitamin D metabolism in the body. Awareness campaigns and early diagnosis are crucial to prevent the health complications associated with Vitamin D deficiency.

Market Research Overview

Vitamin D, a vital nutrient for maintaining strong bones and teeth, plays a crucial role in calcium, magnesium, and phosphate absorption. Deficiencies of this fat-soluble vitamin can lead to bone disorders such as osteoporosis and rickets. Abnormal levels of Vitamin D can be detected through various testing methods, including Radioimmunoassay and HPLC, in hospitals, diagnostic laboratories, home care settings, and standalone clinical laboratories. Factors contributing to Vitamin D deficiency include sedentary lifestyles, sunlight exposure, and nutrition issues. Reimbursement policies and awareness campaigns are essential for early diagnosis and treatment of deficiencies. Vitamin D testing is crucial for identifying medical conditions like osteomalacia, weakness, fatigue, muscle aches, muscle twitching, depression, irritability, lethargy, developmental delay, and bone changes. Vitamin D deficiency affects infants, children, the elderly, pregnant women, and the population at large. Preventive healthcare and diagnostic tests are key initiatives in the global Vitamin D testing market, with health organizations and healthcare authorities promoting awareness through campaigns and events. The half-life of 25 hydroxy vitamin D in plasma serum is around 2 weeks, making regular testing necessary. Private agencies and new market initiatives continue to expand the market's global presence and production capacities.

Table of Contents:

1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation

• Product
• 25-hydroxyvitamin D Testing
• 1 25-dihydroxyvitamin D Testing
• End-user
• Diagnostic Laboratories
• Hospitals And Physician Clinics
• Home Care Settings
• Geography
• North America
• Europe
• Asia
• Rest Of World (ROW)
• Technology
• Radioimmunoassay
• ELISA
• LC-MS
• Others
• Indication
• Osteoporosis
• Rickets
• Thyroid Disorders
• Vitamin D Deficiency
• Others

7 Customer Landscape
8 Geographic Landscape
9 Drivers, Challenges, and Trends
10 Company Landscape
11 Company Analysis
12 Appendix

About Technavio

Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.

With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

View original content to download multimedia:https://www.prnewswire.com/news-releases/vitamin-d-testing-market-to-grow-by-usd-182-6-million-from-2024-2028--as-awareness-of-vitamin-ds-role-in-health-and-immunity-boosts-demand-report-on-how-ai-is-redefining-market-landscape---technavio-302366915.html

SOURCE Technavio